Ardelyx Inc (ARDX) Directors and Executive Officers

Officers & Directors

William Bertrand, Jr.
Director

Onaiza Cadoret-Manier
Director

Justin Renz
Chief Financial and Operations Officer (Principal Financial Officer)

David Mott
Chairman of the Board of Directors

Richard Rodgers
Director

Michael Raab
President, Chief Executive Officer and Director (Principal Executive Officer)

Robert Bazemore
Director

Robert Felsch
Senior Vice President and Chief Accounting Officer (Principal Accounting Officer)

M. Lundberg
Director

Muna Bhanji
Director ,

Ardelyx inc currently has 489 employees.

News about Ardelyx inc Key Personnel

Navigating the Complex Terrain of IBS-C: Ardelyxs Journey Amidst Financial Challenges and Patient Needs

In an era where healthcare innovation is paramount, Ardelyx, Inc. a biopharmaceutical entity based in Waltham, Massachusetts, has recently made strides in addressing a critical gastrointestinal disorder—irritable bowel syndrome with constipation (IBS-C)—through the publication of a comprehensive review article. This piece, featured in Clinical and Experimental Gastroenterology , highlights not only the significant patient burden associated with IBS-C but also the evolving therapeutic landscape within the United States.IBS-C is a condition that affects millions, leading to persistent discomfort, impaired quality of life, and considerable healthcare costs. The newly published review details the multifacet...

Ardelyx Boosts Leadership Team with Appointment of BioPharma Veteran Mike Kelliher as EVP of Corporate Development and Strategy

Ardelyx, a biopharmaceutical company dedicated to developing groundbreaking medicines for unmet medical needs, has announced the appointment of Mike Kelliher as the Executive Vice President of Corporate Development and Strategy. With an extensive background in the biopharmaceutical industry, Kelliher brings invaluable expertise in mergers and acquisitions, business development, finance, and operational leadership from his tenure at prominent biotechnology and pharmaceutical companies.
Details and Impact:
- March 25, 2024: Ardelyx, Inc. reveals the addition of Mike Kelliher to their leadership team as the new EVP of Corporate Development and Strategy.
- Kelliher possesses over 20 years o...